Clinical Trial

Carotid Intima-media Thickness in Dialysis Patients and Traditional Risk Factors

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
* Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD) patients. * Carotid intima-media thickness (CIMT) is a validated surrogate marker for atherosclerosis. * Both traditional cardiovascular risk factors (hypertension, diabetes, dyslipidemia) and dialysis-specific factors (mineral metabolism disorders, dialysis duration) contribute to vascular damage.
Trial Details
NCT Number NCT07558239
Lead Sponsor Minia University
Conditions Dialysis Patients, Hypertension, Atherosclerosis
Enrollment 100 participants
Start Date 2026-04-24
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-30